asparlas is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Servier Pharmaceuticals Llc. The primary component is Calaspargase Pegol.
Product ID | 72694-515_25fc7d15-4a8f-4c12-a603-aeeac73e4998 |
NDC | 72694-515 |
Product Type | Human Prescription Drug |
Proprietary Name | asparlas |
Generic Name | Calaspargase Pegol |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2019-09-27 |
Marketing Category | BLA / BLA |
Application Number | BLA761102 |
Labeler Name | Servier Pharmaceuticals LLC |
Substance Name | CALASPARGASE PEGOL |
Active Ingredient Strength | 750 U/mL |
Pharm Classes | Asparaginase [CS],Asparagine-specific Enzyme [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2019-09-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA761102 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-09-27 |
Ingredient | Strength |
---|---|
CALASPARGASE PEGOL | 750 U/mL |
SPL SET ID: | 6585bd0d-bd78-4341-9e87-0f7664821f05 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ASPARLAS 87452086 5950575 Live/Registered |
SERVIER IP UK LIMITED 2017-05-16 |